Corporate Action30 Jul 2026, 04:15 pm
Venmax Drugs Allots 7.53 Lakh Equity Shares on Warrant Conversion
AI Summary
Venmax Drugs and Pharmaceuticals Ltd announced the allotment of 7,53,334 equity shares following the conversion of an equal number of convertible warrants. The conversion was exercised by one warrant holder, Dinesh Muddu Kotian (Non-Promoter). The equity shares were issued at a price of ₹20 each (face value ₹10, premium ₹10). The company received ₹15 per warrant as the balance exercise price, totaling ₹1,13,00,010. This allotment increases the company's paid-up capital to ₹14,48,39,290, comprising 1,44,83,929 equity shares.
Key Highlights
- 7,53,334 equity shares allotted upon warrant conversion.
- Conversion exercised by Non-Promoter Dinesh Muddu Kotian.
- Issue price set at ₹20 per share (₹10 face value, ₹10 premium).
- Paid-up capital increased to ₹14.48 Crores.
- Total funds received from conversion: ₹1.13 Crores.
Price Impact
More from VENMAX